Evidence map›Paper›PMID 41838079›Full record

ArticleRadiologie (Heidelberg, Germany)2026

[Basal ganglia and movement disorders-Part 2: … and if it is not Parkinson's disease? : Nondegenerative causes and neuroradiological patterns].

Malvina Garner

Abstract readEnglish Abstract
PubMed Publisher
In one paragraph

Article in Radiologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Malvina GarnerKlinik für diagnostische und interventionelle Neuroradiologie, Universitätskliniken des Saarlandes, Kirrberger Str., 66421, Homburg Saar, Deutschland. malvina.garner@uks.eu.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Nondegenerative disorders involving the basal ganglia frequently do not present clinically as a primary parkinsonian syndrome, but rather in the context of acute or subacute neurological symptoms such as altered level of consciousness, epileptic seizures, encephalopathy, or newly emerging hyperkinetic movement disorders. In these clinical scenarios, neuroimaging is often performed without a clear etiological hypothesis and primarily serves as an initial diagnostic orientation. Due to their end-arterial vascular supply, high metabolic demand, and central role within distributed motor and cognitive networks, the basal ganglia are particularly vulnerable to vascular, metabolic-toxic, inflammatory, and genetic insults. Accordingly, nondegenerative disorders often exhibit characteristic-and in some cases highly specific-patterns of involvement, the systematic analysis of which allows for rapid etiological stratification. This article provides a structured overview of the most relevant nondegenerative causes of movement disorders with basal ganglia involvement and describes typical neuroradiological patterns observed in vascular, metabolic-toxic, genetic, neoplastic, and infectious-inflammatory conditions. In addition, current developments in magnetic resonance imaging are discussed with respect to their potential and inherent limitations. Neuroradiological imaging remains a central tool in the evaluation of nondegenerative movement disorders, guiding etiological classification, and directing further diagnostic work-up.

Indexed as

Basal Ganglia DiseasesMovement DisordersNeuroimagingBasal GangliaDiagnosis, DifferentialHumansMagnetic Resonance ImagingParkinson DiseaseBasal ganglia involvementDifferential diagnosisMetabolic and toxic encephalopathyNondegenerative parkinsonismVascular and inflammatory basal ganglia lesions

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.